Arthrosi Therapeutics is a biotechnology company that focuses on drug discovery and development.
Arthrosi Therapeutics has raised $60.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2025.
Arthrosi Therapeutics's investors include Viva BioInnovator, Viva Ventures Biotech Fund, Xiamen Changrong Investment Management, Guangrun Health Industry, Reichstein Biotech.
Arthrosi Therapeutics is headquartered in Laguna Hills, United States.
Arthrosi Therapeutics is a biotechnology company that focuses on drug discovery and development.
Arthrosi Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Arthrosi Therapeutics — Funding & Investors." VCBacked, June 23, 2025, https://www.vcbacked.co/company/arthrosi-therapeutics. Accessed August 14, 2026.
VCBacked. (2025). Arthrosi Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/arthrosi-therapeutics
{{cite web |title=Arthrosi Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/arthrosi-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated